Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells
about
Using the TAP component of the antigen-processing machinery as a molecular adjuvantRecent insights in the pathogenesis of post-transplantation lymphoproliferative disordersMYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.Kinetic analysis of the specific host response to a murine gammaherpesvirusBurkitt lymphoma: pathogenesis and immune evasion.Inhibition of heavy chain and beta2-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replicationEpstein-Barr virus oncogenesis and the ubiquitin-proteasome system.Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid ResiduesThe ubiquitin C-terminal hydrolase UCH-L1 regulates B-cell proliferation and integrin activation.Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma.Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.Immune escape mechanisms in ALCL.Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.
P2860
Q25256237-82F564A7-7F81-4993-BB7E-8569AFF6558BQ28075701-A7BEC4CB-01C5-4557-867E-C2AFD23F9107Q34048911-FF8F8F2C-ABE4-4A94-B883-AB58F63FBF7FQ34068985-132D2013-941E-47C4-B424-6A7F96E97AF7Q34189497-70891D7B-8FC7-48EE-8565-279329C79797Q35635291-05A06248-71C1-4BB4-AEAB-33140674EAF9Q35691576-98092F57-77A9-45C4-8312-206B0C4686BBQ36434322-199C6EB9-C6FB-46DD-9057-CB872B50F2B8Q38346195-5858176E-B3C0-4CA8-B5E6-732564F2ACF9Q39015659-9B4C581E-27FB-455B-9E95-1E65646A230BQ39588027-17EFFA25-7FCD-4FF6-85E2-07A4AA6B63EAQ40185161-529A3C43-E4C8-4DF1-A586-678E317F3ECBQ40703241-AD975E3E-0812-4D0F-AE6D-B91DC51A3D5EQ41059342-989F3600-B6AD-4391-814A-DA8FA4596D17Q42432005-8F25B43F-4851-423A-936A-2C83939FCBB3Q43011113-AC99030B-89DD-4BAE-A397-4133065A9BF1Q53294096-F497B85C-9A1C-48D7-AA41-0845B88B9F96
P2860
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@ast
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@en
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@nl
type
label
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@ast
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@en
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@nl
prefLabel
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@ast
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@en
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@nl
P2093
P2860
P3181
P1476
Defective presentation of MHC ...... es in Burkitt's lymphoma cells
@en
P2093
P2860
P3181
P356
10.1002/(SICI)1097-0215(19961009)68:2<251::AID-IJC19>3.0.CO;2-D
P407
P577
1996-10-09T00:00:00Z